Visiongain Report Provides Critical Market-led Data on the $8.3bn Pre-Filled Device Manufacturing Market

LONDON, Oct. 31, 2019 /PRNewswire/ -- The Pre-Filled Device Manufacturing market is estimated to reach $8.3bn in 2024, growing at a CAGR of 9.5% throughout the forecast period.

http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg

The majority of revenues for pre-filled syringe manufacturers, including component manufacturers and pen injector/autoinjector manufacturers, came from developed markets.

How this 224-page Visiongain report delivers:

-- Provides an overview and revenue forecasts of the global pre-filled injectable devices market from 2019 to 2029

-- Profiles of selected leading companies in the pre-filled injection device manufacturing:
-- Leading pre-filled syringe manufacturers
-- Leading pre-filled injectable component manufacturers
-- Leading pen injector and autoinjector manufacturers
-- Leading pre-filled injectable devices contract manufacturers

To request sample pages from this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/top-pre-filled-injection-device-manufacturers-2019-2029/#download_sampe_div

-- Companies profiled in this report:
-- Aptar Stelmi
-- Becton, Dickinson, & Co (BD)
-- Bespak Injectables
-- Boehringer Ingelheim
-- Catalent
-- Dätwyler Holding
-- Gerresheimer
-- Haselmeier
-- Laboratorios Farmacéuticos ROVI
-- Nemera.
-- Nipro
-- Ompi
-- Owen Mumford
-- Roselabs Group.
-- Schott
-- SHL Group
-- Tip-top
-- Vetter Pharma
-- Weigao Group Pharmaceutical Packaging Products Company
-- West Pharmaceutical Services.
-- Ypsomed

-- Information provided for the selected leading companies, when available:
-- Overview of the company
-- Historical Revenues
-- Revenue forecasts from 2019-2029
-- A SWOT analysis
-- A competitive analysis
-- Products & Services
-- Business Developments: Expansion, new products, mergers, acquisitions, collaborations.

-- This report also discusses the key trends in the pre-filled injection device manufacturing market.

-- 109 charts unavailable elsewhere

To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/top-pre-filled-injection-device-manufacturers-2019-2029/

Did you know that we also offer a report add-on service? Email sara.peerun@visiongain.com to discuss any customized research needs you may have.

Companies covered in the report include:

AbbVie
Actavis
AdvalTech
Aesica
Agência Nacional de Vigilância Sanitária (ANVISA) [Brazil]
Albany Molecular Research (AMRI)
AluPlast
Amcor Glass Tubing (part of Nipro)
American Stelmi (part of Aptar Stelmi)
Amgen
Amylin Pharmaceuticals
Antares Pharma
ANVISA
Apax Partners
Aptar Stelmi
AptarGroup
Aptuit
AstraZeneca
Aucta Pharmaceuticals
B. Braun Medical
Balda Group
Baxter
Baxter BioPharma Solutions (part of Baxter)
Baxter International
Bayer
BD Medico
Becton, Dickinson & Co. (BD)
Berlin-Chemie
Berry Plastics Group
Bespak
Biocon
Biogen Idec
Bionime
Blackstone Group
Boehringer Ingelheim
Boehringer Ingelheim BioXcellence
Bristol-Myers Squibb
C.R. Bard
Cambridge Consultants
CAPS (Central Admixture Pharmacy Services)
Cardinal Health
Cardium Therapeutics
CareFusion
Carl Zeiss Foundation
Carmel Pharma
Catalent
CeifiT
Cellular Research
Centers for Disease Control and Prevention (CDC)
Centor
Clere (part of Ompi)
Columbia Engineered Rubber
ConnectMeSmart GmbH
Consort Medica
Corning
Crucell Spain
Daikyo Seiko
Dätwyler
Dätwyler Holding
Debiopharm Group
Diagenode
Disetronic Group
Disetronic Group (part of Roche)
Dong-A Pharmaceutical
Dr. Reddy's Laboratories
DS WorldMed
Duoject
DuPont
Elcam Medical
Eli Lilly
EMA (European Medicines Agency)
European Commission
European Medicines Agency (EMA)
Euticals
EVER Nuro Pharma
Federal Commission for Protection against Health Risks
Ferring Pharmaceuticals
Food and Drug Administration (FDA) [US]
Fresenius
Future Injection Technologies
Gadea Pharmaceutical Group
GenCell Biosystems
Genentech
Genovi Pharmaceuticals Limited
GeroPharm
Gerresheimer
GSK
Hankook Sealtech
Hanmi Pharmaceutical Co
Haselmeier
HealthPrize
HEKUMA
Helvoet Pharma
Hospira
Hospira One2One (part of Hospira)
Hyaluron Contract Manufacturing (HCM, part of AMRI)
Incepta Pharmaceuticals
Injectronics
Insulet
J&J
Jabil Circuit
Janssen Biotech
Japanese MHLW (Ministry for Health, Labour, and Welfare)
Johnson & Johnson
Juniper Pharmaceuticals
Korea Food and Drug Administration (KFDA)
Laboratorios Farmacéuticos ROVI
LifeScan
Lupin
McKesson
Medicines and Healthcare Products Regulatory Agency (MHRA) [UK]
MedImmune (part of AstraZeneca)
Medimop Medical Projects (part of West Pharmaceutical Services)
Medtronic
Menarini Group
Merck & Co.
Merck KGaA
MG Sterile Products (part of Nipro)
MGlas
Ministry of Health, Labor and Welfare (MHLW) [Japan]
MJ Biopharm
Montagu
Montagu Private Equity
NanoPass Technologies
Nemera
Neutral Glass and Allied Industries
Nipro
Nipro Europe (part of Nipro)
Nipro Glass (part of Nipro)
Nipro Medical (part of Nipro)
Nipro North America
Novartis
Novo Nordisk
Nuova Ompi (Formerly Ompi, Italian part of Stevanato Group)
Nycomed
Nycomed (part of Takeda)
Nypro
Occupational Safety and Health Administration (OSHA) [US]
Ompi
Opiant Pharmaceuticals
Optrel (part of Stevanato Group)
Origom
Osu Biopharmaceutical Manufacturing
Oval Medical
Owen Mumford
PA Consulting Group
Palatin Technologies
Parker Institute
PATH
Pema Holding
Pfizer
Pharma-Pen (part of West Pharmaceutical Services)
PharmaTap
Pharmstandard
Phillips Medisize
Plastef Investissements
Polfa Tarchomin
Primequal
Primoceler Oy
QuiO
Revolutions Medical
Rexam
Roche
Roselabs Bioscience (part of Roselabs Group)
Roselabs Group
Roselabs Polymers (part of Roselabs Group)
ROVI CM (part of Laboratorios Farmacéuticos ROVI)
Rumpler Technologies
Safety Syringes (part of BD)
Sandoz (part of Novartis)
Sanex Packaging Connections
Sanofi
Sanofi Pasteur
Savient Pharmaceuticals
Scandinavian Health Ltd (SHL Group)
Schering-Plough (part of Merck & Co.)
Schott
Schott Kaisha
Sealing Technologies
Sensile Medical
Sentry BioPharma Services
Shandong Weigao Group Medical Polymer Company
Shanghai Fosun Pharmaceutical
Shire
SHL Group
Smiths Group
Spami (part of Stevanato Group)
Square Pharmaceuticals
Stallergenes
Stelmi Asia (part of Aptar Stelmi)
Stevanato Group
Sungwon Medical
Swedish Orphan Biovitrum (Sobi)
Taisei Kako
Teva
Teva Pharmaceutical Industries
The Medical House
The Parker Institute (part of The Parker Foundation)
The Tech Group (part of West Pharmaceutical Services)
ThinFilm
Tip-Top
Tissue Repair Company (part of Cardium Therapeutics)
Tolmar
Tonghua Dongbao
Triveni Polymers
UCB
UK Medicines and Healthcare Products Regulatory Agency (MHRA)
Unilife
US Agency for International Development
Valerius Biopharma
Vetter Pharma
Watson Pharmaceutical
Weigao Group Pharmaceutical Packaging Products Company
West Company Mexico
West Pharmaceutical India Packaging Private (part of West Pharmaceutical Services)
West Pharmaceutical Services
Wockhardt
World Health Organization (WHO)
WW Medical and Healthcare Company Limited
Ypsomed
Zeon Corporation
Zhongding Sealtech

To see a report overview please e-mail Sara Peerun on sara.peerun@visiongain.com

Related reports:

Global Pre-Filled Syringes Market Forecast 2019-2029

Biologics Market Trends and Forecasts 2019-2029

Pharma Leader Series: Top 30 Ophthalmic Drug Manufacturers 2019-2029

Global Medical Device Contract Manufacturing Market Forecast 2019-2029

Global Influenza Vaccines Market Outlook 2019-2029

Global Vaccines Sales Market Forecast 2019-2029

View original content:http://www.prnewswire.com/news-releases/visiongain-report-provides-critical-market-led-data-on-the-8-3bn-pre-filled-device-manufacturing-market-300945067.html

SOURCE Visiongain